Mifid II research unbundling: “It has changed everything and nothing”
Buyside firms and IRPs explain that the directive’s stated aim – reducing conflicts of interest – has not quite been achieved. In some areas it’s even had the opposite effect, with the rise of corporate-sponsored research
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
